After transformation under new CEO, Leo Pharma touts innovation model and financial progress
Fierce Pharma
MARCH 12, 2024
Taking over as CEO for an aging company in dire financial straits and in need of a slimdown was a challenging assignment for Christophe Bourdon. Taking over as CEO for an aging company in dire financial straits and in need of a slimdown was a challenging assignment for Christophe Bourdon.
Let's personalize your content